Abstract:Background: Gestational diabetes mellitus (GDM) is known to have a teratogenic effect on heart development. Former studies determined that miR-155 is elevated in GDM patients. In the present study, we explored the potential role of miR-155 on high glucose-induced cardiac developmental defects. Methods: Serum miR-155 of GDM patients was determined by using ELISA. Fetal cardiac characteristics were collected by echocardiography. Zebrafish embryos were exposed to 2% D-Glucose in a fluctuating manner. The expression levels of miR-155, Ets1 and cardiac specific genes were evaluated by real-time PCR or western blot. Reactive oxygen species (ROS) were detected by DCFH-DA. Findings: High glucose exposure in zebrafish embryos altered the morphology of the heart, increased the expression of miR-155 and cardiac specific genes. Upregulation of miR-155 activated Igf1-Akt-Gsk3β pathway by targeting Ets1 and increased the production of ROS and may thereby exert teratogenic effect on cardiac development. Knockdown of miR-155 could rescue high glucose-induced zebrafish heart developmental defects. Besides, miR-155 levels are increased in serum from GDM patients and are correlated with fetal cardiac structural changes. Moreover, loss of miR-155 blocked Igf1 survival pathway and induced apoptosis and may thus cause zebrafish cardiac developmental defects. Interpretation: miR-155 is a key molecule for heart development and is involved in high glucose-induced cardiac malformation and it might be a novel biomarker as well as a potential drug target of high glucose-induced cardiac defects. Funding：This work was supported by grants from: (1) the Youth Program of National Natural Science Foundation (NSF)of China (81200125) to LY; (2) the Priority Academic Program Development (PAPD) and the Key Project of Natural Science Foundation of the Higher Education Institutions (17KJA310001) to LY; (3) the Six Talent Peaks Project (STPP) of Jiangsu Province (2015-WSN-032) to ZXT. Declaration of Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Ethics Approval Statement: The studies involving human participants were reviewed and approved by Ethical Committee, Jiangsu province Hospital. The patients/participants provided their written informed consent to participate in this study. Zebrafish maintenance and procedures were conducted in accordance with the medical ethics committee of Nanjing Medical University. All experiments were approved by the medical ethics committee of Nanjing Medical University.

Impact of DNA methyltransferase inhibitor 5‐azacytidine on cardiac development of zebrafish in vivo and cardiomyocyte proliferation, apoptosis, and the homeostasis of gene expression in vitro

Repurposing From Oncology to Cardiology: Low-Dose 5-Azacytidine Attenuates Pathological Cardiac Remodeling in Response to Pressure Overload Injury

Exposure to Acrylamide Disrupts Cardiomyocyte Interactions During Ventricular Morphogenesis in Zebrafish Embryos.

DNA methylation is developmentally regulated for genes essential for cardiogenesis.

Exposure to Acrylamide Induces Cardiac Developmental Toxicity in Zebrafish During Cardiogenesis

miR-29b-3p Inhibitor Alleviates Hypomethylation-Related Aberrations Through a Feedback Loop Between miR-29b-3p and DNA Methylation in Cardiomyocytes

PM2.5-induced Extensive DNA Methylation Changes in the Heart of Zebrafish Embryos and the Protective Effect of Folic Acid.

Tet Inactivation Disrupts YY1 Binding and Long-Range Chromatin Interactions During Embryonic Heart Development

Inhibition of DNA Methylation Attenuates Low‐dose Cadmium‐induced Cardiac Contractile and Intracellular Ca2+ Anomalies

Characterization of Acrylamide-Induced Oxidative Stress and Cardiovascular Toxicity in Zebrafish Embryos.

Endothelin-1 promotes cardiomyocyte terminal differentiation in the developing heart via heightened DNA methylation.

Genome-wide Methylation Analysis Reveals Differentially Methylated CpG Sites and Altered Expression of Heart Development-Associated Genes in Fetuses with Cardiac Defects

DNA methyltransferases inhibitors effectively induce gene expression changes suggestive of cardiomyogenic differentiation of human amniotic fluid‐derived mesenchymal stem cells via chromatin remodeling

DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy

Reduced DNMT1 Levels Induce Cell Apoptosis Via Upregulation of METTL3 in Cardiac Hypertrophy

Cardiac developmental toxicity and transcriptome analyses of zebrafish (Danio rerio) embryos exposed to Mancozeb

Effects of Mir-155 on High Glucose Induced-Cardiac Developmental Defects of Zebrafish Embryos

The Cellular Responses of Autophagy, Apoptosis, and 5-Methylcytosine Level in Zebrafish Cells Upon Nutrient Deprivation Stress

Exposure to Volatile Organic Compounds Induces Cardiovascular Toxicity That May Involve DNA Methylation

The Roles of SMYD4 in Epigenetic Regulation of Cardiac Development in Zebrafish

Hypermethylation of the Bmp4 promoter dampens binding of HIF-1α and impairs its cardiac protective effects from oxidative stress in prenatally GC-exposed offspring